BURLINGTON, ON, Sept. 25, 2012 /CNW/ - EKO INTERNATIONAL INC. (EKO) -
EKNL- Pinksheets -- is pleased to announce that oeBin Ltd., of
Burlington, ON, has been engaged by NeuroVasc Clinical Inc.(NCI), (a
joint venture company owed 51 % by NeuroVasc Medical Inc.(NVMI) and 49%
by EKO.), as NCI's sole distributor representative for FREMS
equipment in the states of New York and Florida.
FREMS (Frequency Rhythmic Electrical Modulation System) equipment is
used in the treatment of Peripheral Neuropathy (damage to nerves in
extremities such as lower legs and feet causing an interruption in
communication between the brain and parts of the body with damaged
With over 60 million diabetics in North America and 60% of them
suffering from Peripheral Neuropathy, the need for this treatment is
Further news is expected to be released in the immediate future in
respect of FREMS and EKO's involvement with the technology and expected
corporate earnings as a result.
In order to clarify the present state of shareholdings in EKO, the
company wishes to confirm that it fully complied with the April Order
by the Chancery Court of Delaware to issue 2,926,224 free trading
shares of EKO, bringing the number of issued and outstanding shares as
of the date of this release from 28,756,746 to 31,682,970 and the
current float of free trading shares as of the date of this release to
EKO will be issuing a further 1,000,000 restricted shares to NeuroVasc
Medical Inc. in consideration for EKO's participation in the NCI Joint
venture which holds the exclusive rights to market FREMS equipment.
SOURCE: EKO INTERNATIONAL CORP.
For further information:
To contact the company by e-mail, please use firstname.lastname@example.org